A sleep specialist and an endocrinologist discuss ways to engage patients in difficult conversations and shared decision-making to better manage the related conditions of sleep apnea and obesity.

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

New research highlights that severe obstructive sleep apnea (OSA) independently predicts elevated C-reactive protein (CRP) ...

More specifically, Zepbound received approval for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity, alongside a reduced-calorie diet and increased physical activity.

Snoring, often dismissed as a mere annoyance, can be a potentially life-threatening condition of obstructive sleep apnea (OSA ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

While the strongest evidence exists that getting sufficient sleep (duration of sleep) is important for overall health , other ...